FDA Approves Sickle Cell Gene Therapy for Young Kids

By News Health
2 hours Ago

(MedPage Today) — The FDA on Wednesday expanded the approval for exagamglogene autotemcel (exa-cel, Casgevy) in severe sickle cell disease with recurrent vaso-occlusive crises and transfusion-dependent beta thalassemia to include children 2 years…

Source link : https://www.medpagetoday.com/hematologyoncology/hematology/122035

Author :

Publish date : 2026-07-02 16:08:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

Endoscopy Radiation Exposure; H. Pylori and Colon Cancer; Gut-Brain Therapies in IBS

Doc's Massage Parlor Plea Deal; Psychiatrist Sues Kaiser; NP Gets 10 Years

New Evidence Links Progestogen Contraceptives to Brain Cancer Risk

Why Danny Glover Is Speaking Publicly About His Alzheimer's Disease

What Misinformation Looks Like in the ICU

Geoengineering could expose plane passengers to sulphuric acid